Reference
Kriulin I, et al. Secukinumab efficacy and safety in Juvenile Idiopathic Arthritis. Pediatric Rheumatology 18 (Suppl. 2): 73 abstr. P268, 2020. Available from: URL: http://doi.org/10.1186/s12969-020-00470-5 [abstract]
Rights and permissions
About this article
Cite this article
Secukinumab. Reactions Weekly 1840, 333 (2021). https://doi.org/10.1007/s40278-021-90476-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-90476-x